cyclophilin
cyp
bind
protein
fkbp
peptidylprolyl
cistran
isomeras
ppias
enzym
catalyz
cistran
interconvers
peptid
bond
amino
termin
prolin
residu
fischer
et
al
hard
et
al
takahashi
takahashi
et
al
cyp
fkbp
origin
identifi
cellular
factor
bind
csa
respect
immunosuppress
use
clinic
prevent
graft
reject
follow
organ
transplant
handschumach
et
al
hard
et
al
therefor
ppias
also
call
immunophilin
action
ppias
lead
chang
protein
conform
takahashi
bind
csa
cyp
fkbp
respect
inhibit
activ
enzym
fischer
et
al
rosen
et
al
takahashi
et
al
howev
inhibit
ppias
activ
csa
insuffici
requir
immunosuppress
function
bierer
et
al
schreiber
csacyp
complex
subsequ
interact
inhibit
calcineurin
cn
phosphatas
involv
activ
transcript
factor
nfat
proper
nfat
function
essenti
gener
product
cell
respons
clipston
crabtre
fruman
et
al
liu
et
al
absenc
immunosuppress
cn
dephosphoryl
cytoplasm
nfat
lead
nfat
nuclear
transloc
transactiv
downstream
gene
particip
immun
respons
liu
et
al
mccaffrey
et
al
csa
prevent
dephosphoryl
subsequ
nuclear
transloc
nfat
lead
immunosuppress
cyp
subtyp
found
mammal
tabl
subcellular
local
cyp
vari
cypa
primarili
found
cytoplasm
cypb
cypd
cype
distribut
endoplasm
reticulum
er
mitochondria
nucleu
nuclear
pore
respect
member
cyp
famili
play
role
varieti
cellular
process
includ
immun
respons
transcript
mitochondri
function
cell
death
chemotaxi
describ
number
cyp
famili
member
ideitifi
intens
function
analysi
perform
includ
cypa
cypb
cypd
cypa
abund
cyp
subtyp
found
cell
waldmeier
et
al
primari
factor
mediat
immunosuppress
effect
csa
colgan
et
al
howev
even
absenc
csa
cypa
play
import
role
regul
immun
respons
seen
cypadefici
mice
cypaknockout
mice
allerg
phenotyp
increas
serum
ige
level
tissu
infiltr
mononuclear
cell
eosinophil
mast
cell
colgan
et
al
relat
increas
dysregul
activ
cell
cypaknockout
cell
tyrosin
kinas
itk
signal
molecul
crucial
develop
respons
constitut
activ
itk
member
tec
famili
tyrosin
kinas
particip
signal
transduct
cascad
lead
cell
activ
cypa
bind
itk
neg
regul
itk
activ
brazin
et
al
thu
cypa
play
suppress
role
develop
cell
respons
interact
itk
studi
report
sever
nonimmun
system
role
cypa
cypa
interact
apoptosisinduc
factor
aif
promot
aifmedi
chromatinolysi
apoptosi
cand
et
al
addit
cypa
interact
membranebound
guanyl
cyclasea
gca
receptor
atrial
natriuret
factor
anf
chen
et
al
gca
anf
involv
cardiovascular
homeostasi
cypa
appear
function
endogen
inhibitor
gca
activ
compet
anf
bind
interact
cypa
prolactin
receptor
sy
et
al
transcript
factor
yang
et
al
observ
exact
role
cypa
process
remain
unclear
cypa
also
observ
bind
dna
zincdepend
manner
mous
macrophag
cell
line
krummrei
et
al
howev
bestcharacter
role
identifi
cypa
normal
cellular
physiolog
rather
cofactor
human
immunodefici
viral
life
cycl
see
cypb
origin
identifi
cyp
famili
member
bear
signal
sequenc
lead
er
lumen
secretori
pathway
price
et
al
specif
function
cypb
poorli
understood
yeast
twohybrid
screen
use
cypb
bait
identifi
interact
calciumsign
modul
cyclophilin
ligand
caml
bram
crabtre
caml
locat
cytoplasm
face
er
membran
holloway
bram
caml
particip
calcium
signal
transduct
pathway
essenti
peripher
cell
develop
tran
et
al
howev
import
cypb
bind
caml
function
remain
unknown
cypb
also
enhanc
prolactindriven
cell
prolifer
rycyzyn
et
al
promot
nuclear
retrotransloc
prolactin
direct
interact
addit
cypb
potenti
prolactininduc
transactiv
promot
dissoci
repressor
rycyzyn
cleveng
cypb
also
associ
interferon
regulatori
factor
irf
obata
et
al
extracellular
cypb
bind
platelet
allain
et
al
initi
transmembran
influx
calcium
ion
kinas
activ
platelet
adhes
collagen
accumul
evid
suggest
cyp
particular
cypa
cypb
mediat
intercellular
commun
similar
cytokin
cyp
secret
cell
respons
inflammatori
stimuli
oxid
stress
jin
et
al
seko
et
al
sherri
et
al
xu
et
al
act
potent
chemoattract
neutrophil
sherri
et
al
eosinophil
xu
et
al
cell
allain
et
al
cypa
cypb
recogn
cell
surfac
receptor
cyp
bind
lead
erk
activ
chemotaxi
pushkarski
et
al
yurchenko
et
al
yurchenko
et
al
cypd
play
critic
role
mitochondri
function
cell
death
tanveer
et
al
ischemiainduc
necrosi
eg
follow
heart
attack
stroke
accumul
calcium
increas
reactiv
oxygen
speci
ro
trigger
open
pore
inner
mitochondri
membran
known
membran
permeabl
transit
pore
mptp
halestrap
calcium
overload
ro
induc
conform
chang
adenin
nucleotid
translocas
ant
key
compon
regul
open
mptp
inner
mitochondri
membran
open
mptp
lead
mitochondri
swell
ruptur
outer
membran
releas
small
molecul
waldmeier
et
al
cypd
locat
within
matrix
mitochondria
bind
ant
facilit
conform
chang
crompton
et
al
woodfield
et
al
cypdknockout
cell
necrosi
induc
calcium
ro
decreas
apoptot
cell
death
induc
cytokin
anticanc
agent
unaffect
bain
et
al
nakagawa
et
al
cypdknockout
mice
also
experienc
reduc
cardiac
injuri
follow
reperfus
ischemia
thu
cypd
key
molecul
involv
cell
death
process
regul
activ
steroid
receptor
sr
duina
et
al
owensgrillo
et
al
ratajczak
et
al
sr
includ
glucocorticoid
receptor
estrogen
receptor
androgen
receptor
progesteron
receptor
nuclear
hormon
receptor
exert
transcript
activ
follow
steroid
ligand
bind
nuclear
transloc
absenc
steroid
ligand
sr
form
complex
heat
shock
protein
togeth
immunophilin
cytoplasm
immunophilin
control
sr
activ
increas
receptor
avid
hormon
ligand
ppiasedepend
conform
chang
upon
hormon
bind
immunophilin
complex
dissoci
leav
homodimer
sr
transloc
nucleu
transactiv
downstream
gene
although
report
cyp
subtyp
tabl
precis
function
signific
larg
unknown
signific
role
cyp
vv
replic
first
identifi
analysi
sever
csa
analog
abil
cyclosporin
suppress
vv
replic
correl
inhibit
cyp
function
damaso
moussatch
vv
infect
stabil
cypa
lead
accumul
cypa
castro
et
al
vv
infect
cell
cypa
reloc
peripher
region
nucleu
coloc
site
viru
product
cypa
incorpor
viral
particl
locat
viral
core
cypa
interact
nucleocapsid
protein
vsv
bose
et
al
like
vv
cypa
incorpor
vsv
viral
particl
although
bind
incorpor
cypa
occur
beyond
viru
serotyp
function
role
cypa
viral
life
cycl
appear
straindepend
inhibit
cyp
activ
csa
reduc
primari
transcript
vsvnew
jersey
vsvnj
vsvindiana
vsvind
serotyp
cypa
activ
requir
replic
vsvnj
greater
extent
vsvind
author
suggest
differenti
requir
cypa
like
result
evolutionari
pressur
lineag
develop
nucleocapsid
protein
np
sever
acut
respiratori
syndrom
coronaviru
sarscov
bind
cypa
luo
et
al
anoth
group
report
cypa
incorpor
sarscov
particl
chen
et
al
extracellular
cypa
bind
cell
surfac
treatment
peptid
block
bind
inhibit
viral
infect
thu
cypa
may
involv
sarscov
invas
host
cell
interact
np
respect
cypa
play
import
role
viral
life
cycl
cypa
found
interact
gag
luban
et
al
cypa
reportedli
incorpor
viral
particl
frank
et
al
thali
et
al
gene
target
studi
demonstr
cypa
among
cyp
subtyp
essenti
prolifer
braaten
luban
within
life
cycl
cypa
play
multipl
role
differ
interact
partner
includ
earli
step
prior
revers
transcript
braaten
et
al
mlynar
et
al
steinkasser
et
al
although
cypa
incorpor
virion
bind
ca
domain
gag
polyprotein
frank
et
al
ott
et
al
thali
et
al
incorpor
requir
viral
infect
instead
target
cell
express
cypa
import
product
infect
viral
replic
hatziioann
et
al
sokolskaja
et
al
known
sever
decad
host
cell
express
differ
restrict
factor
prevent
infect
certain
retrovirus
cullen
sever
recent
studi
suggest
cypa
modul
sensit
restrict
factor
earli
life
cycl
prior
revers
transcript
host
restrict
factor
origin
identifi
use
express
clone
recogn
ca
limit
retroviru
prolifer
stremlau
et
al
tower
et
al
show
cypa
regul
activ
host
restrict
factor
tower
et
al
disrupt
cypaca
bind
introduc
point
mutat
ca
treat
human
cell
csa
decreas
infect
convers
loss
cypaca
bind
greatli
enhanc
infect
simian
cell
berthoux
et
al
kootstra
et
al
sayah
et
al
result
hypothesi
propos
luban
et
al
ca
bind
cypa
prevent
normal
antivir
effect
mediat
infect
human
cell
interact
mediat
restrict
nonhuman
primat
cell
sokolskaja
et
al
luban
press
mechan
restrict
modul
ca
recognit
cypa
remain
unclear
studi
clearli
need
resolv
import
issu
life
cycl
host
respons
infect
cypa
may
import
aspect
infect
cypa
interact
pushkarski
et
al
heparan
saphir
et
al
vpr
zander
et
al
envelop
glycoprotein
endrich
gehr
although
relev
interact
verifi
hcv
major
caus
agent
chronic
liver
diseas
chronic
hepat
liver
cirrhosi
hepatocellular
carcinoma
liang
et
al
hcv
infect
seriou
health
problem
affect
approxim
million
individu
worldwid
poynard
et
al
current
standard
therapi
hcv
restrict
interferon
ifn
pegylatedifn
either
alon
combin
ribavirin
treatment
agent
howev
fail
produc
sustain
viru
elimin
one
half
patient
di
biscegli
et
al
altern
effect
strategi
combat
hcv
greatli
need
hcv
encod
singl
polypeptid
cleav
host
hcvencod
proteas
includ
gener
set
function
protein
genom
replic
hcvencod
rnadepend
rna
polymeras
rdrp
protein
essenti
hcv
genom
replic
possibl
target
develop
antihcv
therapeut
di
biscegli
et
al
small
molecul
compound
target
develop
efficaci
examin
clinic
trial
di
biscegli
et
al
addit
viral
enzym
host
cell
factor
requir
viral
replic
may
provid
option
develop
novel
antivir
agent
disrupt
function
host
cell
deriv
factor
particularli
appeal
mutat
rate
host
protein
much
less
viral
encod
protein
less
give
rise
drugresist
virus
howev
host
factor
requir
viral
genom
replic
identifi
host
protein
need
identifi
develop
optim
antivir
therapi
side
effect
time
limit
number
host
protein
found
involv
hcv
genom
replic
biolog
relev
one
snare
famili
protein
regul
vesicl
biogenesi
protein
sort
membran
fusion
bind
hcv
interact
regul
presenc
hcv
protein
subcellular
compart
perform
viral
genom
replic
evan
et
al
gao
et
al
tu
et
al
member
fbox
protein
famili
involv
ubiquitin
pathway
geranylgeranyl
cell
wang
et
al
associ
geranylgeranylationdepend
manner
regul
hcv
genom
replic
howev
mechan
action
hcv
genom
replic
known
addit
recent
found
cypb
cofactor
hcv
replic
host
cell
may
repres
new
target
antihcv
therapeut
watashi
et
al
first
discuss
role
cypb
hcv
genom
replic
follow
therapeut
implic
discoveri
hcv
treatment
identifi
csa
antihcv
agent
use
hcv
replicon
system
cell
cultur
system
support
hcv
genom
replic
lohmann
et
al
csa
inhibit
hcv
genom
replic
potent
watashi
et
al
sinc
time
sever
group
made
similar
observ
firpi
et
al
nakagawa
et
al
paeshuys
et
al
shown
fig
cellular
treatment
csa
decreas
hcv
rna
level
approxim
watashi
et
al
csa
also
reduc
express
hcvencod
protein
undetect
level
fig
contrast
effect
product
hcv
rna
protein
fig
b
differ
csa
suggest
csa
prevent
viral
genom
replic
independ
cn
effector
common
csa
mediat
immunosuppress
antihcv
effect
csa
mediat
pathway
distinct
watashi
et
al
abil
csa
inhibit
hcv
genom
replic
correl
inhibit
cyp
activ
watashi
et
al
moreov
altern
cyp
inhibitor
sanglifehrin
also
decreas
level
hcv
rna
thu
inhibit
cyp
activ
essenti
antihcv
effect
csa
strongli
suggest
cyp
play
direct
import
role
hcv
genom
replic
moreov
specif
knockdown
cypb
rnai
reduc
hcv
rna
titer
knockdown
cypa
cypc
cype
cyph
effect
hcv
replic
activ
data
indic
cypb
play
critic
role
hcv
genom
replic
effect
cypb
hcv
genom
replic
mediat
direct
interact
demonstr
vitro
cell
watashi
et
al
fig
cypb
bind
hcv
protein
involv
viral
replic
bind
hcv
genom
rna
order
function
rdrp
cypb
cypa
promot
rna
bind
activ
stimul
hcv
genom
replic
cell
fig
function
support
cypb
essenti
effici
replic
hcv
genom
csa
block
interact
cypb
lead
reduc
rna
bind
fig
thu
cypb
serv
cellular
cofactor
hcv
genom
replic
antihcv
activ
csa
analog
correl
abil
inhibit
cyp
function
watashi
et
al
dissoci
cypb
greatli
reduc
extent
hcv
genom
replic
observ
suggest
inhibit
cypb
may
repres
novel
therapeut
strategi
hcv
possibl
examin
two
report
use
stronger
cyp
inhibitor
csa
paeshuys
et
al
use
csa
analog
inhibit
cyp
activ
paeshuys
et
al
compound
inhibit
hcv
replic
potent
csa
author
specul
might
attract
drug
candid
treatment
individu
hcvhiv
coinfect
csa
deriv
also
inhibit
replic
use
nonimmunosuppress
csa
deriv
target
cyp
goto
et
al
ishii
et
al
inhibit
cyp
enzymat
activ
twofold
csa
rosenwirth
et
al
increas
inhibit
correl
greater
suppress
hcv
genom
replic
csa
especi
lower
dose
cotreat
cell
led
synergist
antihcv
effect
higher
dose
treatment
three
week
elimin
hcv
rna
host
cell
detect
level
immunosuppress
patient
viral
infect
undesir
nonimmunosuppress
variant
csa
inhibit
cyp
activ
like
offer
great
promis
treatment
patient
chronic
hcv
infect
cyp
cellular
ppias
catalyz
conform
chang
protein
role
substrat
protein
famili
cell
wellcharacter
howev
discoveri
signific
cyp
life
cycl
sever
virus
make
protein
virolog
notabl
present
novel
therapeut
antivir
target
analys
role
cyp
viral
life
cycl
reveal
novel
function
protein
well
provid
mechanist
insight
possibl
therapeut
target
